Table: Kobayashi Pharmaceutical - 6-MTH group results
Aug 5 (Reuters)-
Kobayashi Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2025 Jun 30, 2024 Dec 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 69.02 73.14 171.00
(-5.6 pct) (-0.7 pct) (+3.3 pct)
Operating 6.65 9.47 14.00
(-29.8 pct) (-9.0 pct) (-43.7 pct)
Recurring 7.25 10.43 15.30
(-30.6 pct) (-6.6 pct) (-43.0 pct)
Net 3.17 1.44 10.50
(+120.5 pct) (-81.7 pct) (+4.3 pct)
EPS 42.61 yen 19.32 yen 141.25 yen
Ann Div 102.00 yen 104.00 yen
-Q2 div 44.00 yen 43.00 yen
-Q4 div 59.00 yen 60.00 yen
NOTE - Kobayashi Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows